Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$0.09
-4.4%
$0.11
$0.08
$0.34
$5.82M0.041.88 million shs1.85 million shs
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
$0.00
$2.91
$82.80
$1.90M2.031,362 shs6,500 shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$2.05
+2.5%
$2.17
$1.72
$5.35
$6.58M0.8717,994 shs10,482 shs
WOK
WORK Medical Technology Group LTD Ordinary Shares
$0.80
+14.1%
$0.50
$0.36
$8.45
$11.66MN/A1.18 million shs651,740 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
0.00%-14.13%-12.57%-55.02%-71.80%
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.00%0.00%0.00%0.00%0.00%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.00%-17.01%-1.23%-8.00%-55.56%
WOK
WORK Medical Technology Group LTD Ordinary Shares
0.00%+39.66%+65.09%-5.39%+69,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
3.0096 of 5 stars
3.23.00.00.04.11.71.3
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/AN/AN/AN/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.1761 of 5 stars
3.55.00.00.01.81.71.3
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
2.33
Hold$2.002,177.90% Upside
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.00
N/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.00
Buy$5.00143.90% Upside
WOK
WORK Medical Technology Group LTD Ordinary Shares
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RSLSD, WOK, STRR, and LYRA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$8.00 ➝ $5.00
3/14/2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$2.00 ➝ $2.00
(Data available from 5/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$1.19M4.91N/AN/A$1.56 per share0.06
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
$610K0.00N/A0.08$341.84 per share0.00
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$57.17M0.12$0.34 per share6.11$14.63 per share0.14
WOK
WORK Medical Technology Group LTD Ordinary Shares
$11.51M1.01N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$62.68M-$1.21N/AN/AN/A-6,635.76%-125.07%-59.74%8/12/2025 (Estimated)
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
-$81.15MN/A0.00N/AN/A-668.58%-163.22%-52.10%N/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$25.13M-$3.43N/AN/AN/A-12.41%-8.72%-4.62%8/12/2025 (Estimated)
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/AN/A0.00N/AN/AN/AN/AN/A

Latest RSLSD, WOK, STRR, and LYRA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million
5/6/2025Q1 2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$0.15-$0.12+$0.03-$0.13$0.16 million$0.18 million
3/20/2025Q4 2024
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 million
3/13/2025Q4 2024
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$0.12-$0.16-$0.04-$0.16$0.21 million$0.21 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/AN/AN/AN/AN/A
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/A
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/A
3.64
3.64
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.05
1.17
1.07
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.21
2.05
1.60
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
5066.27 million62.39 millionOptionable
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
50354,000N/ANot Optionable
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
4603.21 million2.14 millionNot Optionable
WOK
WORK Medical Technology Group LTD Ordinary Shares
22614.59 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Lyra Therapeutics stock logo

Lyra Therapeutics NASDAQ:LYRA

$0.09 0.00 (-4.36%)
Closing price 04:00 PM Eastern
Extended Trading
$0.09 0.00 (-0.80%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

ReShape Lifesciences stock logo

ReShape Lifesciences OTCMKTS:RSLSD

ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

Star Equity stock logo

Star Equity NASDAQ:STRR

$2.04 +0.04 (+2.00%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

WORK Medical Technology Group LTD Ordinary Shares NASDAQ:WOK

$0.80 +0.10 (+14.14%)
Closing price 04:00 PM Eastern
Extended Trading
$0.77 -0.03 (-4.01%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.